|
Feb 21
|
These Biotech Stocks Aren't Profitable But Still Make Elite IBD 50
|
|
Feb 21
|
US Stocks Trading Below Estimated Value In February 2025
|
|
Feb 21
|
BeiGene (ONC) Soars 3.2%: Is Further Upside Left in the Stock?
|
|
Feb 20
|
High Growth Tech Stocks in the United States to Watch
|
|
Feb 13
|
BeiGene to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27
|
|
Feb 12
|
Is There An Opportunity With BeiGene, Ltd.'s (NASDAQ:ONC) 41% Undervaluation?
|
|
Dec 30
|
BeiGene’s Tevimbra approved in US for first-line gastric cancer treatment
|
|
Oct 10
|
Here’s Why BeiGene, Ltd. (BGNE) Rallied in Q3
|
|
Oct 7
|
BeiGene (BGNE) Moves 5.3% Higher: Will This Strength Last?
|
|
Aug 28
|
Wall Street Analysts See a 27.84% Upside in BeiGene (BGNE): Can the Stock Really Move This High?
|
|
Aug 28
|
3 US Stocks That Could Be Trading At A Discount
|
|
Aug 28
|
BeiGene to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
|
|
Aug 27
|
FDA grants fast track status to BeiGene’s BGB-16673 for CLL/SLL
|
|
Aug 26
|
BeiGene, Ltd. (BGNE) Just Flashed Golden Cross Signal: Do You Buy?
|
|
Aug 26
|
BeiGene’s BGB-16673 Receives U.S. FDA Fast Track Designation for CLL/SLL
|
|
Aug 9
|
BeiGene Second Quarter 2024 Earnings: Beats Expectations
|
|
Aug 8
|
Beyond the Balance Sheet: What SWOT Reveals About BeiGene Ltd (BGNE)
|
|
Aug 7
|
BeiGene Enters Next Phase of Global Growth with Announcement of Second Quarter 2024 Financial Results and Corporate Updates
|
|
Jul 24
|
BeiGene opens biologics facility in New Jersey, US
|
|
Jul 23
|
BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility, Continues Global Expansion to Deliver Medicines to More Patients Around the World
|